MYC and neoplasm: Considering the increased interest of the clinical myeloma community in tumor prevention (192), Vk*MYC and related models may also afford opportunities for the preclinical evaluation of candidate interventions to block the progression of high-risk MGUS and SMM to frank myeloma.